AAAAAA

   
Results: 1-11 |
Results: 11
Characterization of initiated cells in N-methylnitrosourea-induced carcinogenesis of the CNS in the adult rat
Authors: Kokkinakis, DM Watson, ML Honig, LS Rushing, EJ Mickey, BE Schold, SC
Citation: Dm. Kokkinakis et al., Characterization of initiated cells in N-methylnitrosourea-induced carcinogenesis of the CNS in the adult rat, NEURO-ONCOL, 3(2), 2001, pp. 99-112
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American brain tumor consortium study. (vol 2, pg 34, 2000)
Authors: Schold, SC Kuhn, JG Chang, SM Bosik, ME Robins, HI Mehta, MP Spence, AM Fulton, D Fink, KL Prados, MD
Citation: Sc. Schold et al., A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American brain tumor consortium study. (vol 2, pg 34, 2000), NEURO-ONCOL, 3(2), 2001, pp. 123-123
Thresholds of O-6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide
Authors: Kokkinakis, DM Bocangel, DB Schold, SC Moschel, RC Pegg, AE
Citation: Dm. Kokkinakis et al., Thresholds of O-6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide, CLIN CANC R, 7(2), 2001, pp. 421-428
Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice
Authors: Kokkinakis, DM Hoffman, RM Frenkel, EP Wick, JB Han, QH Xu, MX Tan, YY Schold, SC
Citation: Dm. Kokkinakis et al., Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice, CANCER RES, 61(10), 2001, pp. 4017-4023
A phase II study of paclitaxel in patients with recurrent malignant gliomausing different doses depending upon the concomitant use of anticonvulsants - A North American Brain Tumor Consortium report
Authors: Chang, SM Kuhn, JG Robins, HI Schold, SC Spence, AM Berger, MS Mehta, MP Pollack, IF Rankin, C Prados, MD
Citation: Sm. Chang et al., A phase II study of paclitaxel in patients with recurrent malignant gliomausing different doses depending upon the concomitant use of anticonvulsants - A North American Brain Tumor Consortium report, CANCER, 91(2), 2001, pp. 417-422
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American Brain Tumor Consortium study
Authors: Schold, SC Kuhn, JG Chang, SM Bosik, ME Robins, HI Mehta, MP Spence, AM Fulton, D Fink, KL Prados, MD
Citation: Sc. Schold et al., A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American Brain Tumor Consortium study, NEURO-ONCOL, 2(1), 2000, pp. 34-39
Potentiation of BCNU antitumor efficacy by 9-substituted O-6-benzylguanines. Effect of metabolism
Authors: Kokkinakis, DM Moschel, RC Pegg, AE Schold, SC
Citation: Dm. Kokkinakis et al., Potentiation of BCNU antitumor efficacy by 9-substituted O-6-benzylguanines. Effect of metabolism, CANC CHEMOT, 45(1), 2000, pp. 69-77
Eradication of human medulloblastoma tumor xenografts with a combination of O-6-benzyl-2 '-deoxyguanosine and 1,3-bis(2-chloroethyl)-1-nitrosoureal
Authors: Kokkinakis, DM Moschel, RC Pegg, AE Schold, SC
Citation: Dm. Kokkinakis et al., Eradication of human medulloblastoma tumor xenografts with a combination of O-6-benzyl-2 '-deoxyguanosine and 1,3-bis(2-chloroethyl)-1-nitrosoureal, CLIN CANC R, 5(11), 1999, pp. 3676-3681
Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American brain tumor consortium report
Authors: Chang, SM Kuhn, JG Robins, HI Schold, SC Spence, AM Berger, MS Mehta, MP Bozik, ME Pollack, I Schiff, D Gilbert, M Rankin, C Prados, MD
Citation: Sm. Chang et al., Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American brain tumor consortium report, J CL ONCOL, 17(3), 1999, pp. 984-990
Neurologic problems in oncology
Authors: DeAngelis, LM Schold, SC
Citation: Lm. Deangelis et Sc. Schold, Neurologic problems in oncology, BLU BOOK PR, 20, 1999, pp. 289-304
Phase II study of Didemnin B in central nervous system tumors: A SouthwestOncology Group study
Authors: Taylor, SA Giroux, DJ Jaeckle, KA Panella, TJ Dakhil, SR Schold, SC
Citation: Sa. Taylor et al., Phase II study of Didemnin B in central nervous system tumors: A SouthwestOncology Group study, INV NEW DR, 16(4), 1998, pp. 331-332
Risultati: 1-11 |